US Patent No. 9,481,912

Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
Nov 04, 2016

Longhorn Vaccines and Diagnostics has been awarded US Patent No. 9,481,912, "Compositions and methods for detecting and identifying nucleic acid sequences in biological samples."

The New York Times Magazine writes that proteomics might be better poised than genomics to say when someone is falling ill.

In an editorial, Nature calls for the end to the exploitation of foreign postdocs.

Bloomberg profiles IndieBio, a startup incubator for the life sciences.

In Nucleic Acids Research this week: collection of epigenome-wide association study data, updated BloodSpot database, and more.

Nov
29
Sponsored by
Schott

This webinar will discuss how understanding the relative performance characteristics of glass and polymer substrates for in vitro diagnostic applications such as microarrays and microfluidics can help to optimize diagnostic performance.

Dec
03
Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the National Institutes of Health evaluated a novel in situ hybridization approach and applied it to study splice variants related to schizophrenia.

Dec
04
Sponsored by
Sophia Genetics

This webinar will discuss the use of clinical-grade exome analysis application in complex case investigations.

Dec
12
Sponsored by
Illumina

This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.